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Abstract: Smoking is an important risk factor in the development of head and neck cancer. 
However, little is known about its effects on postoperative complications in head and neck 
cancer surgery. We performed a retrospective analysis on 535 consecutive laryngeal cancer 
patients submitted to open partial laryngectomy at the Otolaryngology-Head and Neck 
Surgery Department of Florence University to evaluate a possible correlation between 
smoking and surgical complications. Patients were grouped in non smokers and smokers 
and evaluated for airway, swallowing, local and fistula complications by multivariate 
analysis: 507 (95%) patients were smokers, 69% presented supraglottic, 30% glottic and 
1% transglottic cancer. The most common operation was supraglottic horizontal laryngectomy 
in 58%, followed by supracricoid partial laryngectomy in 27% and frontolateral 
hemilaryngectomy in 15% of cases. The incidence of overall complications was 30%, 
airway complications representing the most frequent (14%), followed by swallowing (7%), 
local (6%) and fistula complications (3%). Smokers developed more local complications  
(p = 0.05, univariate, p = 0.04, multivariate analysis) and pharyngocutaneous fistula  
(p = 0.01, univariate, p = 0.03, multivariate analysis). 
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1. Introduction 
Smoking is the most important risk factor in head and neck cancer [1]. According to a large  
case-control study, over 90% of laryngeal cancer cases in Southern Europe could be prevented by 
avoiding smoking [2]. Its role in the carcinogenetic process, the mechanisms of DNA genetic changes, 
mutations in oncogenes and tumor suppressor genes have already been described in lung and head and 
neck cancer [3–5]. Free radicals and oxidative damage in tobacco-related carcinogenesis have also 
been investigated in inhalation studies of tobacco smoke in laboratory animals [6–10]. 
However, tobacco exposure also represents a risk factor for the development of perioperative 
surgical complications [11]. Robbins et al. [12] described impaired nutritional status and alcohol 
consumption, duration of surgery, type of surgical wound, complexity of the procedure, use of flaps, 
blood replacement and the use of drains, nasogastric tubes and tracheostomies as the major causes of 
wound infections. Moreover, head and neck cancer treatment often includes a combination of surgery, 
radiotherapy and chemotherapy, which increase the difficulty of wound healing, especially in a 
population with a mean age of 60 years, with a higher incidence of comorbidities and a preoperative 
debilitated physical state [13,14]. Smokers with head and neck cancer have considerable difficulty 
tolerating these treatments, due to smoking-related comorbidities such as vascular, cardiac and 
pulmonary disease. 
Wound healing is fundamental in a region where function and anatomic form are strictly 
interdependent. Head and neck surgical procedures require entry into the mucosa of the aerodigestive 
tract, exposing the surgical wound to oropharyngeal secretions and bacteria [15,16]. Multiple factors 
contribute to poor wound healing. In head and neck cancer surgery this can result in exposure of vital 
structures, including the great vessels [17,18], infection and pharyngocutaneous fistula, and the 
potential for life-threatening bleeding. 
While the relationship between smoke and wound healing has been studied for reconstructive head 
and neck cancer surgery [19,20], little is known about non-reconstructive surgery. Hence, we focused 
on a series of consecutive patients submitted to conservative laryngeal surgery, in order to analyze the 
impact of smoke on wound healing in this specific subgroup, and define possible risk factors 
responsible for the onset of postoperative complications. 
2. Experimental 
We performed a retrospective analysis on 535 consecutive patients submitted to open partial 
laryngectomy for primary or recurrent laryngeal squamous cell carcinoma between 1982 and 2007, 
treated at the Otolaryngology-Head and Neck Surgery Department of Florence University. 
Table 1 shows patient and tumor characteristics. Ages ranged from 24 to 79 years (mean 57.9, 
median 59); the majority (95%) of patients were smokers and about half of them (48%) were also 
alcohol abusers. 
Early stage tumors (classified as T1 and T2) were the most common ones (almost 90%). In 69% of 
cases the region involved was the supraglottic larynx, in 20% of patients we found positive neck lymph 
nodes at clinical examination. 
Table 2 gives details of surgery for patients submitted to primary partial laryngectomy (PPL) and 
salvage partial laryngectomy (SPL) following radiotherapy. 
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Table 1. Patient and tumor characteristics. 
Characteristics  Aspects Number of Patients (535) 
Age group 
<60 years 285 (53%) 
≥60 years 250 (47%) 
Smoking status 
Non smokers 28 (5%) 
Smokers 507 (95%) 
Alcohol consumption 
No alcohol consumption 281 (52%) 
Alcohol abuse 254 (48%) 
Tumor subsite 
Glottic tumor 154 (30%) 
Supraglottic tumor 372 (69%) 
Transglottic tumor 9 (1%) 
cT * classification 
1 251 (48%) 
2 227 (42%) 
3 41 (7%) 
4 16 (3%) 
cN ** classification 
0 433 (80%) 
1 73 (14%) 
2 27 (5.6%) 
3 2 (0.4%) 
* cT = clinical tumor stage, ** cN = clinical neck stage. 
Table 2. Details of laryngectomy. 
Features Aspects 
Number of Patients 
All patients  
(n = 535) 
Primary PL *  
(n = 516) 
Salvage PL *  
(n = 19) 
Type 
Frontolateral 82 (15%) 82 (16%) 0 (0%) 
CHP ** 105 (20%) 92 (18%) 13 (68%) 
CHEP *** 39 (7%) 33 (6%) 6 (32%) 
SHL ʃ 309 (58%) 309 (60%) 0 (0) 
Neck dissection 
No 282 (53%) 265 (51%) 17 (89%) 
Yes 253 (47%) 251 (49%) 2 (11%) 
Type of neck dissection 
None 282 (53%) 265 (51%) 17 (90%) 
SND ʃ ʃ 48 (9%) 47 (9%) 1 (5%) 
mRND ʃ ʃ ʃ 205 (38%) 204 (40%) 1 (5%) 
* PL = partial laryngectomy, ** CHP = crico-hyoido-pexy, *** CHEP = crico-hyoid-epiglotto-pexy,  
ʃ SHL = supraglottic horizontal laryngectomy, ʃ ʃ SND = selective neck dissection, ʃ ʃ ʃ mRND = modified 
radical neck dissection. 
Five hundred and sixteen (95%) patients had PPL, while 19 patients (3.5%) had SPL. Supraglottic 
horizontal laryngectomies (SHL) was the most frequently performed operation (58%), followed  
by supracricoid partial laryngectomies (27%), including both cricohyoidopexy (CHP) or  
cricohyoido-epiglottopexy (CHEP), and frontolateral laryngectomies (FLHL) in 15% of cases. Two 
hundred and fifty-three patients (47%) were also submitted to neck dissection. 
According to our Institutional policy, all patients eligible for partial surgery showed at preoperative 
evaluation: Karnofsky physical index superior to 80%, no dyspnea whilst climbing two flights of  
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stairs, satisfactory pulmonary functional tests according to Morris and Koski [21] and basal pO2  
values above 85 mmHg. Furthermore, patients with severe cardio-vascular diseases, diabetes mellitus, 
gastro-oesophageal reflux, severe chronic obstructive pulmonary disease and rheumatoid arthritis were 
considered not eligible for partial laryngectomy. Follow-up times ranged from 2 to 372 months (mean 
74.6 months, median 60.5 months). 
In agreement to the existing literature [22] complications were categorized into local (surgical 
wound infection or dehiscence, subcutaneous emphysema, operative site bleeding, dehiscence of pexy), 
swallowing (hypopharyngeal/laryngeal stenosis and dysphagia), airway (broncho-tracheal stenosis  
and pneumonia) and fistula. To identify patient and tumor factors predictive of complications we 
performed univariate analysis according to Fisher’s exact test, considering age, smoking and alcohol 
status, T classification, N classification, primary radiation treatment and type of partial laryngectomy 
as dependent variables. Logistic regression multivariate analysis was performed entering significant 
data at the univariate analysis. A p value less or equal to 0.05 was considered statistically significant. 
Statistical analysis was conducted with STATA 9.1 (Stata Corporation, College Station, TX, USA). 
3. Results and Discussion 
Table 3 summarizes the proportion of patients with postoperative complications. Overall, 30% of 
patients developed a postoperative complication following partial laryngectomy. Airway complications 
were the most frequent ones as they occurred in 73 patients (14%); swallowing complications occurred 
in 39 patients (7%); local complications and laryngocutaneous fistula had lower incidence rates, 
having affected 33 patients (6%) and 15 patients (3%), respectively. 
Table 3. Postoperative complications after partial laryngectomy. 
Complication 
Number of Patients  
All Patients  
(n = 535) 
Primary PL *  
(n = 516) 
Salvage PL *  
(n = 19) 
p value 
Overall 
No 375 (70%) 359 (70%) 16 (84%) 
0.61 
Yes 160 (30%) 157 (30%) 3 (16%) 
Local 
No 502 (94%) 483 (94%) 19 (100%) 
1.0 
Yes 33 (6%)  33 (6%) 0 (0%) 
Swallowing 
No 496 (93%) 479 (93%) 17 (89%) 
0.68 
Yes 39 (7%) 37 (7%) 2 (11%) 
Airway 
No 462 (86%) 443 (86%) 19 (100%) 
0.34 
Yes 73 (14%) 73 (14%) 0 (0%) 
Fistula 
No 520 (97%) 502 (97%) 18 (95%) 
0.48 
Yes 15 (3%) 14 (3%) 1 (5%) 
* PL = partial laryngectomy. 
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There were no statistically significant differences concerning the incidence of overall complications 
between patients having primary partial laryngectomy and patients having salvage partial laryngectomy 
following radiotherapy failure (p = 0.11). 
In Table 4, we examine factors that are potentially related to the incidence of local complications. 
Smoking status (p = 0.05) and alcohol abuse (p = 0.03) were statistically associated to a major incidence 
of local complications upon univariate analysis. Smoking and alcohol abuse resulted statistically 
significant upon multivariate analysis (p = 0.04 and p = 0.03, respectively). 
For fistula complications (Table 5), smoking status resulted statistically significant upon univariate 
(p = 0.01) and multivariate analysis (p = 0.03). Fistula did not seem to be related to prior irradiation. 
We did not observe any other correlation between smoke habit and systemic complications such as 
dysphagia and airway complications. 
Table 4. Factors predictive for local complications. 
Characteristics Aspects Patients (n = 535) Complicated 
Univariate Multivariate 
p value p value 
Age 
<60 years 285 (53%) 19 (7%) 0.719 0.845 
>=60 years 250 (47%) 14 (6%)   
Smoking status 
Non smokers 28 (5%) 1 (3.57%) 0.05 0.04 
Smokers 507 (95%) 32 (6.3%)   
Alcohol consumption 
No alcohol 281 (52%) 11 (4%) 0.03 0.03 
Alcohol abuse 254 (48%) 22 (9%)   
Tumor Site 
Supraglottic 372 (69%) 27 (7%) 0.123 0.09 
Glottic 154 (30%) 6 (4%)   
Transglottic 9 (1%) 0 (0%)   
cT * 
1 253 (48%) 13 (5%) 0.705 0.962 
2 226 (42%) 16 (7%)   
3 40 (7%) 3 (7%)   
4 16 (3%) 1 (6%)   
cN ** 
0 433 (80%) 24 (6%) 0.078 0.160 
1 73 (14%) 5 (7%)   
2 27 (5.6%) 3 (10%)   
3 2 (0.4) 1 (50%)   
Surgery type 
Frontolateral 82 (15%) 2 (2%) 0.277 0.069 
CHP ʃ 106 (20%) 9 (9%)   
CHEP ʃ ʃ 38 (7%) 4 (11%)   
SHL ʃ ʃ ʃ 309 (58%) 18 (6%)   
Previous RT *** 
No 516 (96%) 33 (6%) 1.000 0.981 
Yes 19 (4%) 0 (4%)   
* cT = clinical tumor stage, ** cN = clinical neck stage, *** RT = radiotherapy, ʃ CHP = crico-hyoido-pexy, 
ʃ ʃ CHEP = crico-hyoid-epiglotto-pexy, ʃ ʃ ʃ SHL = supraglottic horizontal laryngectomy. 
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Table 5. Factors predictive for pharyngocutaneous fistula. 
Characteristics Aspects Patients (n = 535) Complicated 
Univariate Multivariate 
p value p value 
Age 
<60 years 285 (53%) 9 (3%) 0.794 0.711 
>=60 years 250 (47%) 6 (2%)   
Smoking status 
Non smokers 28 (5%) 0 (0%) 0.01 0.03 
Smokers 507 (95%) 15 (2.96%)   
Alcohol consumption 
No alcohol 281 (52%) 5 (2%) 0.189 0.124 
Alcohol abuse 254 (48%) 10 (4%)   
Tumor Site 
Supraglottic 372 (69%) 12 (3%) 0.570 0.132 
Glottic 163 (30%) 3 (2%)   
cT * 
Transglottic 9 (1%) 0 (0%)   
1 253 (48%) 6 (2%) 0.901 0.612 
2 226 (42%) 8 (4%)   
3 40 (7%) 1 (2%)   
4 16 (3%) 0 (0%)   
cN ** 
0 433 (80%) 13 (3%) 0.075 0.923 
1 73 (14%) 1 (1%)   
2 27 (5.6%) 0 (0%)   
3 2 (0.4%) 1 (50%)   
Surgery type 
Frontolateral 82 (15%) 1 (1%) 0.556 0.319 
CHP ʃ 106 (20%) 4 (4%)   
CHEP ʃ ʃ 38 (7%) 2 (5%)   
SHL ʃ ʃ ʃ 309 (58%) 8 (3%)   
Previous RT *** 
No 516 (96%) 14 (3%) 0.351 0.519 
Yes 19 (4%) 1 (5%)   
* cT = clinical tumor stage, ** cN = clinical neck stage, *** RT = radiotherapy, ʃ CHP = crico-hyoido-pexy, 
ʃ ʃ CHEP = crico-hyoid-epiglotto-pexy, ʃ ʃ ʃ SHL = supraglottic horizontal laryngectomy. 
Smoking is the most important risk factor in head and neck cancer [1]. In this series 95% of patients 
were smokers. Supraglottic cancer developed in about 70% of cases. Only 3% of patients were 
submitted to open partial laryngectomy for a recurrence after radiotherapy failure while the remaining 
97% were primary partial laryngectomy. The incidence of overall complications was 30%, airway 
complications representing the most common (14%), followed by swallowing (7%), local (6%) and 
pharyngocutaneous fistula complications (3%). Smoking status and alcohol abuse were statistically 
associated to a major incidence of local complications upon univariate analysis (p = 0.05 and p = 0.03, 
respectively). Also upon multivariate analysis, smoking and alcohol abuse resulted statistically 
significant (p = 0.04 and p = 0.03, respectively). Smoking status was also associated to an increased 
incidence of pharyngocutaneous fistula complications upon univariate (p = 0.01) and multivariate 
analysis (p = 0.03). 
Although most head and neck surgeons believe that smoking causes increased postsurgical 
complications, there is lack of definitive data supporting this hypothesis. Recently, Lassig et al. [23] 
reviewed the existing evidence on this topic, examining the potential effects of tobacco on perioperative 
complications. Conclusions were relatively consistent among the 36 studies reviewed: approximately 
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half of them showed the association between tobacco and perioperative complications. However, only 
the study of Marin et al. [24] classified tobacco use in an objective well-described manner using 
biomarkers and a tobacco questionnaire. In his series, of the 89 patients submitted to 101 pedicled 
and/or microvascular free flaps, about 37% suffered from minor wound healing or major complications. 
The relative risk for a complication was approximately 2-fold for those patients with an elevated 
preoperative serum cotinine concentration (p = 0.028). Wound complication rate was higher with a 
serum cotinine concentration greater than 10 ng/mL, but the risk had a trend to the statistical 
significance only among females (p = 0.054). He concluded that serum cotinine concentration might 
accurately predict the risk of wound complications after head and neck flap reconstruction. 
The literature that highlights the negative impact of smoking is clearer regarding systemic complications 
as well as in microvascular reconstructive surgery after head and neck cancer extirpation [19,20,24]. In 
our study, the smoking status showed a significant impact only on the development of local and fistula 
complications, while airway and swallowing ones were not significantly increased in smokers. These 
findings have been previously reported by Gallo et al. [25] for the risk of postoperative pneumonia. 
It is unclear how tobacco exposure may negatively influence the wound healing process. Of course 
in smoking patients the incidence of comorbidities is very high and the vascular bed is strongly altered. 
Vascular damage may delay wound healing, therefore smokers who undergo a surgical procedure may 
have a greater risk. 
The mechanisms of vascular damage from smoking are well known [26]. Absorbed nicotine 
stimulates the release of catecholamines, whilst other products injure the arterial endothelium and 
promote atherogenesis. Free radicals and aromatic compounds diminish the endothelial synthesis of 
nitric oxide, causing impaired endothelium-dependent relaxation of arteries. The increased oxidation of 
low density lipoprotein (LDL) in smokers has synergistic effects in promoting monocyte adhesion and 
monocyte migration in the subintimal space. Continued stimulation of intimal cells by oxidized LDL 
leads to the development of atherosclerosis. Smoking also potentiates thrombosis at the dysfunctional 
endothelium by increasing the concentration of plasma fibrinogen and altering the activity of platelets. 
All these proatherogenic effects of smoking are also observed, even if to a lesser extent, in passive 
smokers. Ejaz et al. [27] using a well-defined chicken dorsum excision wound assay, found that 
different components of sidestream whole smoke solutions may have a cumulative negative impact on 
wound healing and related angiogenesis. 
Previous clinical trials on the association between alcohol consumption and postoperative complications 
reported conflicting results. A recent systematic review and meta-analysis [28] evidenced how alcohol 
drinking is not an independent risk factor for surgical site infection and anastomotic leakage in 
gastrointestinal surgery. To our knowledge there exists no study which addresses the same issue in the 
field of otorhinolaryngology. Herein, we were the first to report an association between alcohol abuse 
and local complications. 
In summary, we documented a clear significantly statistical association between smoking exposure 
and postoperative complications in conservative laryngeal cancer surgery. Of course, our preliminary 
data need to be supported by future further prospective trials in which tobacco exposure is better 
analyzed from the biochemical point of view. 
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4. Conclusions 
Tobacco exposure is implicated not only in the pathogenesis of head and neck cancer but also seems 
to play a key role in the development of local complications in patients who undergo conservative 
laryngeal cancer surgery. 
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